Kick Off Meeting 6 and 7 June 2018 in Cape Town, South Africa

On 6-7 June the kick off meeting of MTBVAC in Newborns took place in Cape Town, South Africa. This project contains a Phase 2a dose-defining safety and immunogenicity study is being carried out. The project includes also capacity building to support vaccine efficacy trials in Tuberculosis-endemic regions of Sub-Saharan Africa. The project is part of the EDCTP2 programme supported by the European Union.

Project partners from South Africa (Satvi, UCT), Senegal (CRB-EPLS), Madagascar (IPM), Spain (Biofabri and Unizar) and the Netherlands (TBVI) attended the meeting. Also a representative of EDCTP, Tom Nyirenda, joined the kick off of this project. Furthermore, the Steering Committee held their first face-to-face meeting.

Work package leaders and members had the opportunity to be introduced to each other and to discuss about the study approach. The South African partner Satvi hosted also a visit to their field site. The meeting turned out to be a wonderful and promising start of the project.

Group Picture MTBVAC Infant 6 June 2018 Cape Town Claremont #2

 

EDCTP and EU logo (1)